Article

EVALUATION OF THE EFFECTIVENESS OF GENETIC ENGINEERING BIOLOGICAL THERAPY IN CHILDREN WITH JUVENILE ARTHRITIS WITH A SYSTEMIC BEGINNING

Akhmedova D.I.Republican Specialized Scientific and Practical Medical Center of Pediatrics Tashkent Pediatric Medical InstituteIbragimov A.ARepublican Specialized Scientific and Practical Medical Center of Pediatrics Tashkent Pediatric Medical InstituteAkhmedova N.RRepublican Specialized Scientific and Practical Medical Center of Pediatrics Tashkent Pediatric Medical Institute

Zenodo (CERN European Organization for Nuclear Research)repository2022en

ABI

Abstract

Abstract: The article presents the results of evaluating the effectiveness of a genetically engineered biological drug (tocilizumab) in children with juvenile arthritis with a systemic onset. Analysis of the results of the study showed that the use of a genetically engineered biological drug (tocilizumab) in the treatment of patients with juvenile arthritis with systemic onset contributes to a decrease in disease activity, regression of systemic signs and normalization of laboratory parameters in a significantly short time and improves the prognosis of the disease in these children.

Topics

Hermeneutics and Narrative Identity Aging, Elder Care, and Social Issues Health, Medicine and Society

Identifiers

DOI: 10.5281/zenodo.6556141

Citations and references

Cited by 00 references

Metrics — AkademScholar